Novo Nordisk Launches World's First Once-Weekly Insulin In India
One injection a week instead of one every day. Danish drugmaker Novo Nordisk has launched Awiqli, or insulin icodec, in India-the world's first once-weekly basal insulin-cutting the annual injection count for diabetes patients from 365 to just 52. "When we are launching this Awiqli, you called it a disruption. I call it a solution for Type 2 diabetes," Vikrant Shrotriya, Managing Director of Novo Nordisk India, told NDTV in an exclusive conversation.
